More
    HomeEcosystem NewsAxmed Secures $2 Million Seed Funding to Bridge Access Gap for Essential...

    Axmed Secures $2 Million Seed Funding to Bridge Access Gap for Essential Medicines in Africa

    Published on

    spot_img

    Axmed, a B2B marketplace startup focused on improving access to essential medicines in low- and middle-income countries (LMICs), has secured $2 million in seed funding. This investment, led by Founderful Ventures, fuels Axmed’s efforts to bridge the gap between pharmaceutical manufacturers and healthcare institutions in underserved regions.

    The lack of access to quality and affordable medicines is a critical issue in LMICs, impacting millions of people. Fragmented supply chains, high costs, and the prevalence of counterfeit drugs all contribute to this disparity. Axmed’s platform aims to address these challenges by creating a more streamlined and transparent system.

    Direct Connection, Lower Costs

    Axmed’s marketplace connects manufacturers directly with healthcare providers, such as hospitals and clinics, in LMICs. This approach bypasses traditional multi-layered supply chains, potentially leading to lower costs for essential medications. By aggregating demand from healthcare institutions, Axmed strengthens their buying power, allowing them to negotiate more favorable terms with manufacturers.

    To ensure the platform’s integrity and combat the circulation of counterfeit drugs, Axmed plans to implement stringent regulatory and legal requirements for both buyers and sellers. This commitment to transparency is vital for safeguarding public health in LMICs.

    Expansion Plans and Strategic Partnerships

    The seed funding will support Axmed’s initial launch, targeting LMICs like Kenya, Nigeria, Ethiopia, Tanzania, and Rwanda. The company plans to forge partnerships with faith-based organizations, NGOs, government healthcare providers, and procurement agencies to establish a strong presence in these regions.

    This seed funding follows a $5 million grant Axmed received from the Bill & Melinda Gates Foundation. This earlier support underscores the potential of Axmed’s platform to improve access to maternal and child healthcare in priority countries.

    Mutual Benefit for Buyers and Manufacturers

    Axmed’s CEO and co-founder, Emmanuel Akpakwu, highlights the platform’s value proposition for both sides of the marketplace. By aggregating demand, Axmed empowers healthcare institutions in LMICs, while simultaneously creating a more attractive market opportunity for legitimate pharmaceutical manufacturers.

    The platform also aims to address the information gap for manufacturers. Akpakwu emphasizes the need for manufacturers to gain better visibility into the real size and potential of LMIC markets, allowing them to make informed decisions about market entry.

    Axmed joins a growing wave of digital solutions tackling pharmaceutical supply chain challenges in LMICs. Other players in this space include platforms like Africa Medicines Supply Platform and Xs2Meds, along with healthtech companies like Drugstoc and Remedial Health.

    Axmed’s success will depend on its ability to navigate complex regulatory environments, forge strong partnerships within LMICs, and ultimately connect healthcare institutions with the essential medicines their communities need. The company’s launch is expected later this year, with the seed funding providing a critical springboard for its mission.

    Latest articles

    Meet the VC Funds Deploying Tunisia’s $60m ANAVA Fund of Funds

    To date, ANAVA has committed €45 million across 10 venture capital (VC) funds, including those operating out of Nigeria and Senegal. The fund targets up to 13 funds.

    How Sprintly Partners Is Putting Egyptian Startups on Silicon Valley’s Investment Map

    The initiative aims to provide early and growth-stage startups with direct access to funding, mentorship, and networking opportunities within one of the world’s most competitive startup ecosystems.

    Are You a Celebrity Founder or a King of Control? Dream VC’s New Founder Personality Tool Offers Answers

    Are you prioritizing public image, bossing your teams, chasing valuation, or focusing on profitability? A new tool is here to help founders stay on track.

    Swvl Secures Additional $2 Million in Private Placement to Fuel US Expansion

    Under the agreed terms, investors have committed to a six-month lock-up period and restrictions on share transfers.

    More like this

    Meet the VC Funds Deploying Tunisia’s $60m ANAVA Fund of Funds

    To date, ANAVA has committed €45 million across 10 venture capital (VC) funds, including those operating out of Nigeria and Senegal. The fund targets up to 13 funds.

    How Sprintly Partners Is Putting Egyptian Startups on Silicon Valley’s Investment Map

    The initiative aims to provide early and growth-stage startups with direct access to funding, mentorship, and networking opportunities within one of the world’s most competitive startup ecosystems.

    Are You a Celebrity Founder or a King of Control? Dream VC’s New Founder Personality Tool Offers Answers

    Are you prioritizing public image, bossing your teams, chasing valuation, or focusing on profitability? A new tool is here to help founders stay on track.